MedTrace Logo

Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients

NCT01944098 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-10-26

Study results available
· View outcomes & findings →

Summary

The primary objective is to assess the feasibility and safety of administering continuous intraoperative lidocaine infusions in adult patients undergoing laparoscopic Roux en Y Gastric Bypass (RYGB). The secondary objective is to determine if lidocaine administration versus placebo (dextrose administration) (initiated at the time of anesthesia induction and continued until extubation) will reduce postoperative narcotic requirements.

Conditions

  • Bariatric Surgical Pain

Interventions

DRUG

Lidocaine

DRUG

Placebo

Sponsors & Collaborators

  • University of South Florida

    lead OTHER

Principal Investigators

  • Rachel Karlnoski, PhD · Florida Gulf-to-Bay Anesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-07-31
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01944098 on ClinicalTrials.gov